{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T23:29:31Z","timestamp":1785713371009,"version":"3.56.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057645"],"award-info":[{"award-number":["R01DA057645"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057645"],"award-info":[{"award-number":["R01DA057645"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057645"],"award-info":[{"award-number":["R01DA057645"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057645"],"award-info":[{"award-number":["R01DA057645"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057645"],"award-info":[{"award-number":["R01DA057645"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057645"],"award-info":[{"award-number":["R01DA057645"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057645"],"award-info":[{"award-number":["R01DA057645"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057645"],"award-info":[{"award-number":["R01DA057645"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057645"],"award-info":[{"award-number":["R01DA057645"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057645"],"award-info":[{"award-number":["R01DA057645"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057645"],"award-info":[{"award-number":["R01DA057645"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057645"],"award-info":[{"award-number":["R01DA057645"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057645"],"award-info":[{"award-number":["R01DA057645"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057645"],"award-info":[{"award-number":["R01DA057645"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01368-9","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:34:32Z","timestamp":1766759672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u201cBecause we\u2019re the experts\u201d: centering the expertise of people who use drugs to identify and propose solutions for overdose prevention"],"prefix":"10.1186","volume":"23","author":[{"given":"Erika J.","family":"Bailey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikaela","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Angeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Crews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Mijal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joella","family":"Striebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin J.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Claypool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Seal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Salisbury-Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Westergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Gicquelais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"1368_CR1","doi-asserted-by":"publisher","first-page":"e2457538","DOI":"10.1001\/jamanetworkopen.2024.57538","volume":"8","author":"E Wrigley-Field","year":"2025","unstructured":"Wrigley-Field E, Raquib RV, Berry KM, Morris KJ, Stokes AC. Mortality trends among early adults in the united States, 1999\u20132023. JAMA Netw Open. 2025;8:e2457538. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.57538.","journal-title":"JAMA Netw Open"},{"key":"1368_CR2","unstructured":"Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Provisional drug overdose death counts [Internet [Internet]. National Center for Health Statistics; 2022. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"1368_CR3","doi-asserted-by":"publisher","first-page":"e2514997","DOI":"10.1001\/jamanetworkopen.2025.14997","volume":"8","author":"LA Post","year":"2025","unstructured":"Post LA, Ciccarone D, Unick GJ, D\u2019Onofrio G, Kwon S, Lundberg AL, et al. Decline in US drug overdose deaths by Region, Substance, and demographics. JAMA Netw Open. 2025;8:e2514997. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.14997.","journal-title":"JAMA Netw Open"},{"key":"1368_CR4","unstructured":"CDC. CDC Reports Nearly 24% Decline in U.S. Drug Overdose Deaths [Internet]. CDC Newsroom. 2025 [cited 2025 Oct 10]. https:\/\/www.cdc.gov\/media\/releases\/2025\/2025-cdc-reports-decline-in-us-drug-overdose-deaths.html. Accessed 10 Oct 2025."},{"key":"1368_CR5","doi-asserted-by":"publisher","unstructured":"Dowell D, Nataraj N, Rikard M, Park J, Zhang K, Baldwin G. Why have overdose deaths decreased? Widespread Fentanyl saturation and decreased drug use among key drivers. Lancet Reg Health - Americas. 2025;101226. https:\/\/doi.org\/10.1016\/j.lana.2025.101226.","DOI":"10.1016\/j.lana.2025.101226"},{"key":"1368_CR6","doi-asserted-by":"publisher","first-page":"e2458090","DOI":"10.1001\/jamanetworkopen.2024.58090","volume":"8","author":"MV Kiang","year":"2025","unstructured":"Kiang MV, Humphreys K. Recent drug overdose mortality decline compared with Pre\u2013COVID-19 trend. JAMA Netw Open. 2025;8:e2458090. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.58090.","journal-title":"JAMA Netw Open"},{"key":"1368_CR7","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1001\/jama.2024.15992","volume":"332","author":"JJ Palamar","year":"2024","unstructured":"Palamar JJ, Krotulski AJ. Medetomidine infiltrates the US illicit opioid market. JAMA. 2024;332:1425\u20136. https:\/\/doi.org\/10.1001\/jama.2024.15992.","journal-title":"JAMA"},{"key":"1368_CR8","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(23)01686-0","volume":"402","author":"DT Zhu","year":"2023","unstructured":"Zhu DT, Friedman J, Bourgois P, Montero F, Tamang S. The emerging fentanyl\u2013xylazine syndemic in the USA: challenges and future directions. Lancet Elsevier. 2023;402:1949\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(23)01686-0.","journal-title":"Lancet Elsevier"},{"key":"1368_CR9","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2401177","volume":"391","author":"The HEALing Communities Study Consortium","year":"2024","unstructured":"The HEALing Communities Study Consortium. Community-Based Cluster-Randomized trial to reduce opioid overdose deaths. New Engl J Med Mass Med Soc. 2024;391:989\u20131001. https:\/\/doi.org\/10.1056\/NEJMoa2401177.","journal-title":"New Engl J Med Mass Med Soc"},{"key":"1368_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2105\/AJPH.2024.307887","volume":"115","author":"BDL Marshall","year":"2025","unstructured":"Marshall BDL. Strategies to increase the Population-Level impact of Naloxone distribution in communities highly affected by the overdose crisis. Am J Public Health Am Public Health Association. 2025;115:9\u201311. https:\/\/doi.org\/10.2105\/AJPH.2024.307887.","journal-title":"Am J Public Health Am Public Health Association"},{"key":"1368_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13011-021-00406-6","volume":"16","author":"ZR Salazar","year":"2021","unstructured":"Salazar ZR, Vincent L, Figgatt MC, Gilbert MK, Dasgupta N. Research led by people who use drugs: centering the expertise of lived experience. Subst Abuse Treat Prev Policy. 2021;16:70. https:\/\/doi.org\/10.1186\/s13011-021-00406-6.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"1368_CR12","doi-asserted-by":"publisher","first-page":"103364","DOI":"10.1016\/j.drugpo.2021.103364","volume":"98","author":"C Simon","year":"2021","unstructured":"Simon C, Brothers S, Strichartz K, Coulter A, Voyles N, Herdlein A, et al. We are the researched, the researchers, and the discounted: the experiences of drug user activists as researchers. Int J Drug Policy. 2021;98:103364. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103364.","journal-title":"Int J Drug Policy"},{"key":"1368_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12954-025-01214-y","volume":"22","author":"S Kapler","year":"2025","unstructured":"Kapler S, Hassan H, Jeremiah A, Bryant K, Crespo P, Felix N, et al. Establishing a community advisory board to align harm reduction research with the unique needs of black and Latine communities. Harm Reduct J. 2025;22:74. https:\/\/doi.org\/10.1186\/s12954-025-01214-y.","journal-title":"Harm Reduct J"},{"key":"1368_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/ADM.0000000000000867","volume":"16","author":"SW Stull","year":"2022","unstructured":"Stull SW, Smith KE, Vest NA, Effinger DP, Epstein DH. Potential value of the insights and lived experiences of addiction researchers with addiction. J Addict Med. 2022;16:135. https:\/\/doi.org\/10.1097\/ADM.0000000000000867.","journal-title":"J Addict Med"},{"key":"1368_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12954-019-0306-6","volume":"16","author":"G Brown","year":"2019","unstructured":"Brown G, Crawford S, Perry G-E, Byrne J, Dunne J, Reeders D, et al. Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership. Harm Reduct J. 2019;16:37. https:\/\/doi.org\/10.1186\/s12954-019-0306-6.","journal-title":"Harm Reduct J"},{"key":"1368_CR16","doi-asserted-by":"publisher","unstructured":"Brothers S, Simon C, Vincent L. Community-Driven research with people who use drugs: A virtual project during multiple Epidemics. Sociological methodology. Volume 55. SAGE Publications Inc; 2025. pp. 155\u201381. https:\/\/doi.org\/10.1177\/00811750241281063.","DOI":"10.1177\/00811750241281063"},{"key":"1368_CR17","unstructured":"Volkow N. Improving community engagement in addiction science | National Institute on Drug Abuse (NIDA) [Internet]. Nora\u2019s Blog. 2024 [cited 2025 Oct 17]. https:\/\/nida.nih.gov\/about-nida\/noras-blog\/2024\/11\/improving-community-engagement-in-addiction-science. Accessed 17 Oct 2025."},{"key":"1368_CR18","unstructured":"NIH HEAL Initiative. Patient and Community Engagement Resources [Internet]. 2023 [cited 2025 Oct 17]. https:\/\/heal.nih.gov\/resources\/engagement. Accessed 17 Oct 2025."},{"key":"1368_CR19","unstructured":"Nothing About Us Without Us. Greater, Meaningful Involvement of People Who Use Illegal Drugs: A Public Health, Ethical, and Human Rights Imperative [Internet]. Canadian HIV\/AIDS Legal Network; 2006 [cited 2025 June 16]. https:\/\/www.hivlegalnetwork.ca\/site\/wp-content\/uploads\/2013\/04\/Greater+Involvement+-+Bklt+-+Drug+Policy+-+ENG.pdf. Accessed 16 June 2025."},{"key":"1368_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2307\/3096941","volume":"44","author":"DD Heckathorn","year":"1997","unstructured":"Heckathorn DD. Respondent-Driven sampling: A new approach to the study of hidden populations. Soc Probl Oxf Acad. 1997;44:174\u201399. https:\/\/doi.org\/10.2307\/3096941.","journal-title":"Soc Probl Oxf Acad"},{"key":"1368_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-024-02206-5","author":"AE Rudolph","year":"2024","unstructured":"Rudolph AE, Nance RM, Bobashev G, Brook D, Akhtar W, Cook R et al. Evaluation of respondent-driven sampling in seven studies of people who use drugs from rural populations: findings from the Rural Opioid Initiative. BMC Medical Research Methodology [Internet]. 2024 [cited 2024 May 7];24. https:\/\/doi.org\/10.1186\/s12874-024-02206-5."},{"key":"1368_CR22","unstructured":"Wallerstein N, Duran B, Oetzel JG, Minkler M. Community-Based Participatory Research for Health: Advancing Social and Health Equity. 3rd ed. 2017."},{"key":"1368_CR23","unstructured":"Best Practices for Democratizing Research for Researchers and Community Groups [Internet]. Drug Policy Alliance. [cited 2025 June 17]. https:\/\/drugpolicy.org\/resource\/best-practices-for-democratizing-research-for-researchers-and-community-groups\/. Accessed 17 June 2025."},{"key":"1368_CR24","unstructured":"Recommendations for Community Driven Drug Policy Research [Internet]. Drug Policy Alliance. [cited 2025 June 17]. https:\/\/drugpolicy.org\/resource\/recommendations-for-community-driven-drug-policy-research\/. Accessed 17 June 2025."},{"key":"1368_CR25","unstructured":"Harm Reduction Principles. | National Harm Reduction Coalition [Internet]. [cited 2025 June 16]. https:\/\/harmreduction.org\/about-us\/principles-of-harm-reduction\/. Accessed 16 June 2025."},{"key":"1368_CR26","doi-asserted-by":"publisher","first-page":"204993612311515","DOI":"10.1177\/20499361231151508","volume":"10","author":"ER Weinstein","year":"2023","unstructured":"Weinstein ER, Herrera CM, Pla Serrano L, Mart\u00ed Kring E, Harkness A. Promoting health equity in HIV prevention and treatment research: a practical guide to establishing, implementing, and sustaining community advisory boards. Therapeutic Adv Infect. 2023;10:20499361231151508. https:\/\/doi.org\/10.1177\/20499361231151508.","journal-title":"Therapeutic Adv Infect"},{"key":"1368_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.socscimed.2017.01.027","volume":"176","author":"W Damon","year":"2017","unstructured":"Damon W, Callon C, Wiebe L, Small W, Kerr T, McNeil R. Community-based participatory research in a heavily researched inner City neighbourhood: perspectives of people who use drugs on their experiences as peer researchers. Soc Sci Med. 2017;176:85\u201392. https:\/\/doi.org\/10.1016\/j.socscimed.2017.01.027.","journal-title":"Soc Sci Med"},{"key":"1368_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12954-025-01202-2","volume":"22","author":"DE Banks","year":"2025","unstructured":"Banks DE, Paschke ME, Campbell KD, Bradshaw-Glenn DD, Ghonasgi R, Barr B, et al. CENTER-ing black voices: incorporating lived experience across the research process to advance equity in drug treatment and outcomes. Harm Reduct J. 2025;22:64. https:\/\/doi.org\/10.1186\/s12954-025-01202-2.","journal-title":"Harm Reduct J"},{"key":"1368_CR29","unstructured":"Community Anti-Drug Coalitions of America (CADCA) National Coalition Institute. Community assessment primer: describing your Community, collecting Data, analyzing the issues and Establishing a road map for change. Internet. 2018;p 1\u201358. https:\/\/www.cadca.org\/resource\/assessment-primer-describing-your-community-collecting-data-analyzing-the-issues-and-establishing-a-road-map-for-change\/.."},{"key":"1368_CR30","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1177\/002188637100700404","volume":"7","author":"AL Van de Delbecq","year":"1971","unstructured":"Van de Delbecq AL. A group process model for problem identification and program planning. J Appl Behav Sci SAGE Publications Inc. 1971;7:466\u201392. https:\/\/doi.org\/10.1177\/002188637100700404.","journal-title":"J Appl Behav Sci SAGE Publications Inc"},{"key":"1368_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s10488-010-0327-7","volume":"38","author":"GA Aarons","year":"2011","unstructured":"Aarons GA, Hurlburt M, Horwitz SM. Advancing a conceptual model of Evidence-Based practice implementation in public service sectors. Adm Policy Ment Health. 2011;38:4\u201323. https:\/\/doi.org\/10.1007\/s10488-010-0327-7.","journal-title":"Adm Policy Ment Health"},{"key":"1368_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12954-025-01212-0","volume":"22","author":"RE Gicquelais","year":"2025","unstructured":"Gicquelais RE, Conway CJ, Becker M, Bailey EJ, Bosworth C, Miller R, et al. Exploration of novel harm reduction approaches to increase client engagement (ENHANCE): protocol for a prospective cohort study. Harm Reduct J. 2025;22:81. https:\/\/doi.org\/10.1186\/s12954-025-01212-0.","journal-title":"Harm Reduct J"},{"key":"1368_CR33","unstructured":"Implementation Primer: Putting Your Plan into Action [Internet]. Community Anti-Drug Coalitions of America National Coalition Institute; 2019. https:\/\/www.cadca.org\/wp-content\/uploads\/2019\/02\/implementationcompressed.pdf"},{"key":"1368_CR34","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2105\/AJPH.2012.301069","volume":"103","author":"ML Hatzenbuehler","year":"2013","unstructured":"Hatzenbuehler ML, Phelan JC, Link BG. Stigma as a fundamental cause of population health inequalities. Am J Public Health. 2013;103:813\u201321. https:\/\/doi.org\/10.2105\/AJPH.2012.301069.","journal-title":"Am J Public Health"},{"key":"1368_CR35","doi-asserted-by":"publisher","first-page":"e1002969","DOI":"10.1371\/journal.pmed.1002969","volume":"16","author":"AC Tsai","year":"2019","unstructured":"Tsai AC, Kiang MV, Barnett ML, Beletsky L, Keyes KM, McGinty EE, et al. Stigma as a fundamental hindrance to the united States opioid overdose crisis response. PLoS Med. 2019;16:e1002969. https:\/\/doi.org\/10.1371\/journal.pmed.1002969.","journal-title":"PLoS Med"},{"key":"1368_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2105\/AJPH.2019.305515","volume":"110","author":"DC Des Jarlais","year":"2020","unstructured":"Des Jarlais DC, Feelemyer J, LaKosky P, Szymanowski K, Arasteh K. Expansion of syringe service programs in the united States, 2015\u20132018. Am J Public Health. 2020;110:517\u20139. https:\/\/doi.org\/10.2105\/AJPH.2019.305515.","journal-title":"Am J Public Health"},{"key":"1368_CR37","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/29767342241289008","volume":"46","author":"N Vadiei","year":"2025","unstructured":"Vadiei N, Axon DR, Eckert B. Naloxone distribution models in the united states: A scoping Review. Substance use & addiction journal. SAGE Publications. 2025;46:391\u2013404. https:\/\/doi.org\/10.1177\/29767342241289008.","journal-title":"SAGE Publications"},{"key":"1368_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2105\/AJPH.2024.307583","volume":"114","author":"SN Facente","year":"2024","unstructured":"Facente SN, Humphrey JL, Akiba C, Patel SV, Wenger LD, Tookes H, et al. Funding and delivery of syringe services programs in the united States, 2022. Am J Public Health Am Public Health Association. 2024;114:435\u201343. https:\/\/doi.org\/10.2105\/AJPH.2024.307583.","journal-title":"Am J Public Health Am Public Health Association"},{"key":"1368_CR39","doi-asserted-by":"publisher","first-page":"e2413861","DOI":"10.1001\/jamanetworkopen.2024.13861","volume":"7","author":"X Zang","year":"2024","unstructured":"Zang X, Skinner A, Krieger MS, Behrends CN, Park JN, Green TC, et al. Evaluation of strategies to enhance Community-Based Naloxone distribution supported by an opioid settlement. JAMA Netw Open. 2024;7:e2413861. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.13861.","journal-title":"JAMA Netw Open"},{"key":"1368_CR40","doi-asserted-by":"publisher","first-page":"209679","DOI":"10.1016\/j.josat.2025.209679","volume":"173","author":"K Dunham","year":"2025","unstructured":"Dunham K, Macon EC, Perry A, Tan M, Marshall BDL, Collins AB. A safe place to use: people who use drugs\u2019 perceptions and preferences prior to the implementation of Rhode island\u2019s first overdose prevention center. J Subst Use Addict Treat. 2025;173:209679. https:\/\/doi.org\/10.1016\/j.josat.2025.209679.","journal-title":"J Subst Use Addict Treat"},{"key":"1368_CR41","doi-asserted-by":"publisher","first-page":"2222149","DOI":"10.1001\/jamanetworkopen.2022.22149","volume":"5","author":"A Harocopos","year":"2022","unstructured":"Harocopos A, Gibson BE, Saha N, McRae MT, See K, Rivera S, et al. First 2 months of operation at first publicly recognized overdose prevention centers in US. JAMA Netw Open. 2022;5:2222149.","journal-title":"JAMA Netw Open"},{"key":"1368_CR42","doi-asserted-by":"publisher","first-page":"110878","DOI":"10.1016\/j.drugalcdep.2023.110878","volume":"250","author":"A Loverock","year":"2023","unstructured":"Loverock A, Marshall T, Viste D, Safi F, Rioux W, Sedaghat N, et al. Electronic harm reduction interventions for drug overdose monitoring and prevention: A scoping review. Drug Alcohol Depend. 2023;250:110878. https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.110878.","journal-title":"Drug Alcohol Depend"},{"key":"1368_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/dar.14055","author":"W Rioux","year":"2025","unstructured":"Rioux W, Viste D, Sedaghat N, Rider N, Tek JTW, Perri M, et al. Defining terminology and outcome measures for evaluating overdose response technology: an international Delphi study. Drug Alcohol Rev. 2025. https:\/\/doi.org\/10.1111\/dar.14055.","journal-title":"Drug Alcohol Rev"},{"key":"1368_CR44","doi-asserted-by":"publisher","first-page":"104206","DOI":"10.1016\/j.drugpo.2023.104206","volume":"121","author":"JN Park","year":"2023","unstructured":"Park JN, Tardif J, Thompson E, Rosen JG, Lira JAS, Green TC. A survey of North American drug checking services operating in 2022. Int J Drug Policy. 2023;121:104206. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104206.","journal-title":"Int J Drug Policy"},{"key":"1368_CR45","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/add.70002","volume":"120","author":"EJ Stringfellow","year":"2025","unstructured":"Stringfellow EJ, Dong H, Khatami SN, Lee H, Jalali MS. The association between buprenorphine doses above 16 milligrams and treatment retention in a multi-payer National sample in the united States, 2014 to 2021. Addiction. 2025;120:1198\u2013206. https:\/\/doi.org\/10.1111\/add.70002.","journal-title":"Addiction"},{"key":"1368_CR46","doi-asserted-by":"publisher","first-page":"209616","DOI":"10.1016\/j.josat.2024.209616","volume":"170","author":"D Frank","year":"2025","unstructured":"Frank D, Bennett AS, Cleland CM, Meyerson BE, Russell DM, Walters SM, et al. I still can feel the sickness: withdrawal experiences of people on methadone maintenance treatment. J Subst Use Addict Treat. 2025;170:209616. https:\/\/doi.org\/10.1016\/j.josat.2024.209616.","journal-title":"J Subst Use Addict Treat"},{"key":"1368_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32812-X","author":"JD Lee","year":"2017","unstructured":"Lee JD, Nunes EV, Novo P, Bachrach K, Bailey GL, Bhatt S, et al. Comparative effectiveness of extended-release Naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. Lancet. 2017. https:\/\/doi.org\/10.1016\/S0140-6736(17)32812-X.","journal-title":"Lancet"},{"key":"1368_CR48","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1377\/hlthaff.2023.00951","volume":"43","author":"WD Bradford","year":"2024","unstructured":"Bradford WD, Lozano-Rojas F. Higher rates of homelessness are associated with increases in mortality from accidental drug and alcohol poisonings: study examines the association between homelessness and accidental drug and alcohol mortality. Health Affairs Health Affairs (Project Hope). 2024;43:242\u20139. https:\/\/doi.org\/10.1377\/hlthaff.2023.00951.","journal-title":"Health Affairs Health Affairs (Project Hope)"},{"key":"1368_CR49","doi-asserted-by":"publisher","first-page":"108127","DOI":"10.1016\/j.drugalcdep.2020.108127","volume":"214","author":"J Van Draanen","year":"2020","unstructured":"Van Draanen J, Tsang C, Mitra S, Karamouzian M, Richardson L. Socioeconomic marginalization and opioid-related overdose: A systematic review. Drug Alcohol Depend Elsevier BV. 2020;214:108127. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108127.","journal-title":"Drug Alcohol Depend Elsevier BV"},{"key":"1368_CR50","doi-asserted-by":"publisher","unstructured":"Baker P, Beletsky L, Avalos L, Venegas C, Rivera C, Strathdee SA, Elsevier BV et al. 2019 [cited 2025 July 10]; https:\/\/doi.org\/10.2139\/ssrn.3401985","DOI":"10.2139\/ssrn.3401985"},{"key":"1368_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00668-8","author":"K Weisenthal","year":"2022","unstructured":"Weisenthal K, Kimmel SD, Kehoe J, Larochelle MR, Walley AY, Taylor JL. Effect of Police action on low-barrier substance use disorder service utilization. Harm Reduct J [Internet] Springer Sci Bus Media LLC. 2022. https:\/\/doi.org\/10.1186\/s12954-022-00668-8. [cited 2025 July 10];19.","journal-title":"Harm Reduct J [Internet] Springer Sci Bus Media LLC"},{"key":"1368_CR52","doi-asserted-by":"publisher","first-page":"102618","DOI":"10.1016\/j.drugpo.2019.102618","volume":"76","author":"S Goldenberg","year":"2020","unstructured":"Goldenberg S, Watt S, Braschel M, Hayashi K, Moreheart S, Shannon K. Police-related barriers to harm reduction linked to non-fatal overdose amongst sex workers who use drugs: results of a community-based cohort in metro Vancouver, Canada. Int J Drug Policy Elsevier BV. 2020;76:102618. https:\/\/doi.org\/10.1016\/j.drugpo.2019.102618.","journal-title":"Int J Drug Policy Elsevier BV"},{"key":"1368_CR53","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.drugalcdep.2010.07.008","volume":"113","author":"ASB Bohnert","year":"2011","unstructured":"Bohnert ASB, Nandi A, Tracy M, Cerd\u00e1 M, Tardiff KJ, Vlahov D, et al. Policing and risk of overdose mortality in urban neighborhoods. Drug Alcohol Depend. 2011;113:62\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.07.008.","journal-title":"Drug Alcohol Depend"},{"key":"1368_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40352-023-00256-3","volume":"12","author":"B Ostrach","year":"2024","unstructured":"Ostrach B, Hixon V, Bryce A. When people who use drugs can\u2019t differentiate between medical care and cops, it\u2019s a problem. Compd Risks Law Enforc Harassment Punitive Healthc Policies Health Justice. 2024;12:3. https:\/\/doi.org\/10.1186\/s40352-023-00256-3.","journal-title":"Compd Risks Law Enforc Harassment Punitive Healthc Policies Health Justice"},{"key":"1368_CR55","doi-asserted-by":"publisher","unstructured":"Bosak J, Drainoni M-L, Christopher M, Medley B, Rodriguez S, Bell S et al. Community advisory board members\u2019 perspectives on their contributions to a large multistate cluster RCT: a mixed methods study. J Clin Transl Sci. 8:e1. https:\/\/doi.org\/10.1017\/cts.2023.673","DOI":"10.1017\/cts.2023.673"},{"key":"1368_CR56","unstructured":"The ENHANCE Project [Internet]. The ENHANCE Project. [cited 2025 July 10]. https:\/\/enhanceproject.wisc.edu\/. Accessed 10 July 2025."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01368-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:31:51Z","timestamp":1769599911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-025-01368-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1368"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01368-9","relation":{"references":[{"id-type":"doi","id":"10.1186\/s12874-024-02206-5","asserted-by":"subject"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This Community Advisory Board is convened to provide quality improvement and\/or program evaluation feedback for the ENHANCE Project and is therefore not considered human subjects research per the University of Wisconsin-Madison Health Sciences Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}